Browse Items (659 total)
Sort by:
Invitation to Father Patrick Bastable to join the Ethics Committee
Dr. Mary Redmond invites Father Patrick Bastable to join the Irish Hospice Foundation's Ethics Committee in a letter dated November 03, 1986.
Fact sheet about inaugural IHF Research Committee
A fact sheet about the Research Committee of the Irish Hospice Foundation with a list of members,
Draft terms of reference for first meeting of Research Committee
Draft terms of reference for the first meeting of the Irish Hospice Foundation's Research Committee.
The Irish Hospice Foundation Centre for Death and Bereavement Studies - Strategic Long Term Plan - DRAFT, 2000
A draft of the strategic long term plan for the development of the Bereavement Education Centre.
Speech by Orla Keegan at the opening of Bereavement Education Centre, 2003
Speech made by Orlan Keegan, Head of Education and Research at the Irish Hospice Foundation, at the opening of the Bereavement Education Centre, 13th May, 2003
Minutes of the Bereavement Service Steering Committee
Wednesday 29th March 2000
Minutes from the 29th of March meeting of the Bereavement Services Steering Committee, concerning the development of a Bereavement Education Centre.
Minutes of the Bereavement Service Steering Committee, Thursday 14th June 2000
Minutes from the 14th of June, 2000 meeting of the Bereavement Service Steering Committee, held in Fitzwilliam Place, planning the development of a bereavement education centre.
List of early members of the Research Committee
A list of early members of the Research Committee of the Irish Hospice Foundation, printed on Dr. Mary Redmond's letterhead.
Document regarding the purpose of the Research Committee, with edits
A document regarding the purpose of the proposed Research Committee of the Irish Hospice Foundation, with edits.
Minutes from Ethics and Medical Research Committee, 25-08-88
Minutes from a meeting of the Ethics and Medical Research Committee of the Irish Hospice Foundation, held on August 25, 1988. The meeting was regarding major concerns about the upcoming Control of Clinical Trials Bill.